CD4 and Miyoshi myopathy: Our hypothesis is supported by correlative studies showing that MM patients responsive to ARd had significantly higher CD4+ effector, CD8+ cytotoxic and NK cells but lower immunosuppressive T-regulatory and B-regulatory cells in post-treatment versus pre-treatment BM samples.